Literature DB >> 22946552

Neck lymph nodes in chronic autoimmune thyroiditis: the sonographic pattern.

Davide Brancato1, Roberto Citarrella, Pierina Richiusa, Marco Calogero Amato, Calogero Vetro, Carla Giordano Galluzzo.   

Abstract

BACKGROUND: Neck lymph nodes may be involved in the pathogenesis of chronic autoimmune thyroiditis (CAT). This study was undertaken to identify which of the sonographic features of cervical lymph nodes are readily applicable to patients affected by CAT compared to healthy control subjects.
METHODS: We recruited 106 patients (92 females and 14 males) with CAT and 70 control subjects (53 females and 17 males) without clinical, biochemical, and ultrasonographic evidence of thyroid and neck diseases. We performed laboratory tests (thyrotropin, antithyroperoxidase antibodies, antithyroglobulin antibodies, and ultrasonography) to evaluate in each group: (i) thyroid function, autoimmunity, and morphology; (ii) number, topographic distribution (levels I-VI), and morphology of neck nodes (long-axis diameter; short-axis diameter; short-axis/long-axis ratio; absence or presence of hilus).
RESULTS: Total number of neck nodes with long-axis diameter >10 mm was significantly higher in the CAT group than in the control group (mean±standard deviation [SD]: 3.7±2.4 vs. 0.8±1.3; p<0.001) with significantly increased differences in levels II (1.4±0.8 vs. 0.3±0.5; p<0.001), III (2±1.2 vs. 0.3±0.7; p<0.001), and IV (0.7±0.7 vs. 0.07±0.2; p<0.001). More nodes with a hilus were found in the CAT group than in the control group (mean number of nodes±SD: 2.8±1.9 vs. 0.7±1.1; p<0.001). Short-axis diameter of level III (4.4±1 vs. 3.7±1.2 mm; p=0.002) and level IV nodes (3.9±1 vs. 3.1±0.5 mm p=0.030) was increased in CAT patients when compared with healthy controls.
CONCLUSIONS: The present study is the first one aiming at a systematic description of the sonographic pattern of cervical lymph nodes in CAT. An increased number of benign hyperplastic neck nodes, especially in levels II-IV, appears to be a characteristic sonographic finding associated with CAT.

Entities:  

Mesh:

Year:  2012        PMID: 22946552     DOI: 10.1089/thy.2012.0375

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  7 in total

1.  The presentation of lymph nodes in Hashimoto's thyroiditis on ultrasound.

Authors:  Mark R Jones; Hossam Mohamed; Jennifer Catlin; Daniel April; Zaid Al-Qurayshi; Emad Kandil
Journal:  Gland Surg       Date:  2015-08

2.  The lymph nodes of the central compartment during autoimmune chronic thyroiditis: incidence and ultrasonographic aspects.

Authors:  Francesco Maria Solivetti; Vincenzo Di Donna; Alfredo Pontecorvi
Journal:  Endocrine       Date:  2016-08-23       Impact factor: 3.633

3.  Significance of perithyroidal lymph nodes in benign thyroid diseases.

Authors:  Tomoyuki Ohta; Makiko Nishioka; Norio Nakata; Kunihiko Fukuda; Takako Shirakawa
Journal:  J Med Ultrason (2001)       Date:  2017-06-27       Impact factor: 1.314

4.  Roles of ultrasound and power Doppler ultrasound for diagnosis of Hashimoto thyroiditis in anti-thyroid marker-positive euthyroid subjects.

Authors:  Isin Ceylan; Serkan Yener; Firat Bayraktar; Mustafa Secil
Journal:  Quant Imaging Med Surg       Date:  2014-08

5.  The Presence of Hypoechoic Micronodules in Patients with Hashimoto's Thyroiditis Increases the Risk of an Alarming Cytological Outcome.

Authors:  Dorota Słowińska-Klencka; Martyna Wojtaszek-Nowicka; Mariusz Klencki; Kamila Wysocka-Konieczna; Bożena Popowicz
Journal:  J Clin Med       Date:  2021-02-07       Impact factor: 4.241

6.  Shear wave elastography in the evaluation of level VI lymph nodes in papillary thyroid carcinoma: combined with gray-scale ultrasound ex vivo.

Authors:  Wanying Chang; Lei Tang; Caiwei Lu; Min Wu; Man Chen
Journal:  BMC Cancer       Date:  2018-10-20       Impact factor: 4.430

Review 7.  Drainage of cells and soluble antigen from the CNS to regional lymph nodes.

Authors:  Jon D Laman; Roy O Weller
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-22       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.